Australian Clinical Labs hits record low on poor FY forecast

Australian Clinical Labs

21/05/2024 04:03

** Shares of Australian Clinical Labs  ACL.AX  drop as much
as 0.43% to A$2.33, its record low
    ** Pathology service provider expects its full-year results
at the lower end of previously provided underlying EBIT range of
A$60 mln ($39.92 mln) and A$65 mln
    ** 498,595 shares changed hands by 0255 GMT, 1.1 times the
30-day average volume of shares
    ** Stock has fallen 19.72% this year, as of last close

($1 = 1.5029 Australian dollars)

 (Reporting by Sherin Sunny in Bengaluru)
 ((Sherin.Sunny@thomsonreuters.com))